Identifiability analysis of the standard pharmacokinetic models in DCE MR imaging of tumours

R G P Lopata; N A W van Riel

doi:10.1109/IEMBS.2004.1403341

Identifiability analysis of the standard pharmacokinetic models in DCE MR imaging of tumours

Conf Proc IEEE Eng Med Biol Soc. 2004:2004:1040-3. doi: 10.1109/IEMBS.2004.1403341.

Authors

R G P Lopata¹, N A W van Riel

Affiliation

¹ Dept. of Biomed. Eng., Eindhoven Univ. of Technol., Netherlands.

PMID: 17271860
DOI: 10.1109/IEMBS.2004.1403341

Abstract

The usage of dynamic contrast-enhanced MRI (DCE-MRI) as a clinical tool is still widely assessed. Application of the standard pharmacokinetic models to obtain physiologically relevant parameter values using DCE-MRI in tumours is not trivial, when the temporal resolution is low. Mathematical analysis and analysis by simulation of the identifiability for the generalized and extended Kety models was executed. Parameter estimation was executed using synthetic data sets and maximum likelihood estimation (MLE). The influence of temporal resolution was examined. The generalized and extended Kety model showed a large bias in the parameter estimates (10-120%) for sampling times >4 s, although the estimated variance was relatively low (<1%). This was in accordance with the generated contour plots of the hyperplane of the MLE cost-function. The influence of measurement noise on the input and output turned out to be less significant than the temporal resolution.